Immunomodulatory properties of the metal chelators desferrioxamine and diethylenetriamine penta-acetic acid in vitro

Transplantation

Volumn 62, Issue 9, 1996, Pages 1371-1374

  Scholz, Martin ^a   Biaheta, Roman A ^a   Henrich, Dirk ^a   Cinatl, Jaroslav ^a   Markus, Bernd H ^a   Doerr, Hans W ^a   Cinatl, Jindrich ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRON; CYCLOSPORIN A; DEFEROXAMINE; DEFEROXAMINE MESYLATE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PENTETIC ACID; TACROLIMUS; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL KILLING; CYTOTOXICITY; ENDOTHELIUM CELL; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; IRON CHELATION; LYMPHOKINE ACTIVATED KILLER CELL; MIXED LYMPHOCYTE CULTURE; NATURAL KILLER CELL; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; CELLS, CULTURED; CHELATING AGENTS; CYTOTOXICITY, IMMUNOLOGIC; DEFEROXAMINE; HUMANS; LYMPHOCYTE ACTIVATION; PENTETIC ACID;

EID: 0030447035     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611150-00037     Document Type: Article

References (10)

1. Von Willebrand E, Petterson E, Ahonen J, Häyry P. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986; 42: 364.
2. Summers MR, Jacobs A, Tudway D, Perera P, Ricketts C. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects. Br J Haematol 1979; 42: 547.
3. Cinatl J Jr, Cinatl J, Rabenau H, Gümbel HO, Kornhuber B, Doerr HW. In vitro inhibition of human cytomegalovirus replication by desferrioxamine. Antiviral Res 1994; 25: 73.
4. Gümbel H, Cinatl J, Rabenau H, Doerr HW, Stahl E, Ohrloff C. Antiviral activity of desferrioxamine against human cytomegalovirus resistant to ganciclovir in vitro and in vivo in a patient with AIDS and cytomegalovirus retinitis. Invest Ophthalmol Vis Sci 1995; 36: 180.
5. Cinatl J Jr, Hoffmann F, Cinatl J, et al. In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriamine pentaacetic acid. Antiviral Res 1995; 31: 23.
6. Pippard MJ, Jackson MJ, Modell CB. Subcutaneous diethylene-triamine pentaacetic acid: comparison with desferrioxamine in thalassaemic patients with iron overload. Birth Defects 1988; 23: 105.
7. Weinberg K, Champagne J, Lenarsky C, et al. Desferrioxamine (DFO) inhibition of interleukin 2 receptor (IL2R) expression: therapy of graft versus host disease (GVHD). Blood 1986; 68 (suppl 7): 286.
8. Cinatl J Jr, Scholz M, Weber B, et al. Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells. Transpl Immunol 1995; 3: 313.
9. Voest EE, Vreugdenhil G, Marx JJ. Iron-chelating agents in non-iron overload conditions. Ann Intern Med 1994; 120: 490.
10. Scholz M, Cinatl J, Groß V, et al. Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells. Transplantation 1996; 61: 1763.